| Name | Liu Tianshi, PhD |
|---|---|
| Institution |
Lund University, Mitochondrial Medicine, SE |
| Address | BMC A13, Sölvegatan 17, SE-221 84 |
| City | Lund |
| State/Province | |
| Country | Sweden |
| tianshi.liu@med.lu.se | |
| Weblink | |
| O2k-Network Lab |
Participated at
Labels:
Publications
| Published | Reference | |
|---|---|---|
| Shao 2019 Cardiovasc Diabetol | 2019 | Shao Q, Meng L, Lee S, Tse G, Gong M, Zhang Z, Zhao J, Zhao Y, Li G, Liu T (2019) Empagliflozin, a sodium glucose co-transporter-2 inhibitor, alleviates atrial remodeling and improves mitochondrial function in high-fat diet/streptozotocin-induce diabetic rats. Cardiovasc Diabetol 18:165. |
| Zhang 2018 Cardiovasc Diabetol | 2018 | Zhang X, Zhang Z, Yang Y, Suo Y, Liu R, Qiu J, Zhao Y, Jiang N, Liu C, Tse G, Li G, Liu T (2018) Alogliptin prevents diastolic dysfunction and preserves left ventricular mitochondrial function in diabetic rabbits. Cardiovasc Diabetol 17:160. |
| Zhang 2017 J Am Heart Assoc | 2017 | Zhang X, Zhang Z, Zhao Y, Jiang N, Qiu J, Yang Y, Li J, Liang X, Wang X, Tse G, Li G, Liu T (2017) Alogliptin, a dipeptidyl peptidase-4 inhibitor, alleviates atrial remodeling and improves mitochondrial function and biogenesis in diabetic rabbits. J Am Heart Assoc 6:e005945. |
